Global report - April 16, 2025
Joint Swedish response to the EU’s new life science strategy
Ahead of the EU Commission's presentation of a new strategy for life sciences, four industry organizations in Sweden, Lif – the research-based pharmaceutical companies, SwedenBIO, IKEM, and Swedish Medtech, have submitted a joint statement.
Business article - April 15, 2025
The Finnish OYSTER incubator has been launched – supported by SmiLe Venture Hub
The new incubator is designed to accelerate health and life science innovation in Finland.
Financing - April 14, 2025
Genomic Medicine Sweden receives SEK 80 million to strengthen precision medicine
The money, from the Swedish government, will go to continued efforts to develop and sustainably implement precision medicine in healthcare in the areas of cancer, rare diseases and microbiology.
Business Award - March 4, 2025
Forskaren nominated for Building of the Year 2025
The Forskaren building in Hagastaden, Stockholm, has been nominated for the Building of the Year 2025 award in the “Hotel and Office” category.
Sweden - February 25, 2025
New mapping: Sweden’s Pharmaceutical pipeline
SwedenBIO has started a new mapping of Sweden’s pharmaceutical pipeline to follow its development and strengthen the visibility of Swedish pharmaceutical innovation in the global arena. The last Swedish Drug Discovery and Development Pipeline-report was released in March 2023 and gave a detailed picture of 506 pharmaceutical projects in Swedish companies. Now it’s time to update the analysis and […]
Financing - February 7, 2025
Umeå Biotech Incubator granted SEK 14.6 million in Excellence funding
Umeå Biotech Incubator has been designated as an excellent incubator by the Swedish Innovation Agency, Vinnova, and has been awarded SEK 14.6 million in excellence funding, ensuring financial support through 2029.
